ASX:IBX Imagion Biosystems (IBX) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Imagion Biosystems Stock (ASX:IBX) 30 days 90 days 365 days Advanced Chart Get Imagion Biosystems alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume10.77 million shsAverage VolumeN/AMarket CapitalizationA$3.62 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Imagion Biosystems Limited provides medical imaging technologies using magnetic resonance. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the MagSense nanoparticles for enhancing brain tumor imaging and diagnosis. The company was incorporated in 2016 and is based in San Diego, California. Read More Receive IBX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Imagion Biosystems and its competitors with MarketBeat's FREE daily newsletter. Email Address IBX Stock News HeadlinesImagion Biosystems Full Year 2024 Earnings: AU$0.046 loss per share (vs AU$0.41 loss in FY 2023)March 1, 2025 | ca.finance.yahoo.comLong Shortz with Imagion Biosystems: Moving milestones on next phase cancer detectionFebruary 26, 2025 | msn.com$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.July 5 at 2:00 AM | Brownstone Research (Ad)Imagion to start production of MagSense imaging agent for phase II breast cancer trialFebruary 18, 2025 | msn.comImagion Biosystems Announces New Securities QuotationDecember 14, 2024 | markets.businessinsider.comImagion Biosystems Issues 7.5 Million Unquoted SecuritiesDecember 12, 2024 | markets.businessinsider.comImagion Biosystems Secures Key Approvals at General MeetingDecember 8, 2024 | tipranks.comImagion set to improve cancer detection through molecular MRIDecember 3, 2024 | msn.comSee More Headlines IBX Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Imagion Biosystems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Imagion Biosystems investors own include EMCORE (EMKR), Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU) and VelocityShares 1x Long VSTOXX Futures ETN (EVIX). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:IBX CIKN/A Webwww.imagionbiosystems.com Phone855-564-5264FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.18) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$6.32 million Net Margins-265.26% Pretax MarginN/A Return on Equity139.43% Return on Assets-109.93% Debt Debt-to-Equity Ratio-60.49 Current Ratio0.09 Quick Ratio4.04 Sales & Book Value Annual SalesA$5.92 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow3.00 Book ValueA($0.16) per share Price / BookN/AMiscellaneous Outstanding Shares35,650,000Free FloatN/AMarket CapA$3.62 million OptionableNot Optionable Beta2.05 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (ASX:IBX) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imagion Biosystems Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Imagion Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
